Objective To evaluate the relationship between maternal self-reported race/ethnicity and persistent wheezing illness in former high-risk, extremely low gestational age newborns, and to quantify the contribution of socioeconomic, environmental, and biological factors on this relationship.
Study design
We assessed persistent wheezing illness determined at 18-24 months corrected (for prematurity) age in survivors of a randomized trial. Parents/caregivers were surveyed for wheeze and inhaled asthma medication use quarterly to 12 months, and at 18 and 24 months. We used multivariable analysis to evaluate the relationship of maternal race to persistent wheezing illness, and identified mediators for this relationship via formal mediation analysis.
Results Of 420 infants (25.2 ± 1.2 weeks of gestation and 714 ± 166 g at birth, 57% male, 34% maternal black race), 189 (45%) had persistent wheezing illness. After adjustment for gestational age, birth weight, and sex, infants of black mothers had increased odds of persistent wheeze compared with infants of nonblack mothers (OR = 2.9, 95% CI 1.9, 4.5). Only bronchopulmonary dysplasia, breast milk diet, and public insurance status were identified as mediators. In this model, the direct effect of race accounted for 69% of the relationship between maternal race and persistent wheeze, whereas breast milk diet, public insurance status, and bronchopulmonary dysplasia accounted for 8%, 12%, and 10%, respectively.
Conclusions Among former high-risk extremely low gestational age newborns, infants of black mothers have increased odds of developing persistent wheeze. A substantial proportion of this effect is directly accounted for by race, which may reflect unmeasured environmental influences, and acquired and innate biological differences. (J Pediatr 2018; 198:201-8) .
Trial registration ClinicalTrials.gov: NCT01022580. L ong-term respiratory morbidity is a common adverse outcome of prematurity; premature infants with and without bronchopulmonary dysplasia (BPD) remain at increased risk for respiratory disease throughout childhood. 1, 2 Many of these children suffer from wheezing disorders or asthma, associated with recurrent hospitalizations and long-term medication requirements. 3, 4 Children born very preterm are at highest risk, and those with early recurrent wheeze remain at increased risk for wheeze throughout early childhood. 3, 5 Racial differences in childhood asthma in the US are apparent; non-Hispanic black children are affected at higher rates than non-Hispanic white children. 6 Even after consideration of socioeconomic status (SES) and environmental risk factors, black children have increased odds of wheeze and asthma compared with white children. 7, 8 However, less is known about the relationship between race and wheezing illness among preterm infants, with several studies demonstrating increased occurrence in moderately preterm black children. [9] [10] [11] [12] [13] Increased susceptibility to environmental pollutants and vitamin D intake may be modifying factors. 12 Although studies have identified environmental risk factors (eg, young siblings or exposure to environmental tobacco smoke [ETS] ), few studies have quantified the effect of multiple SES and environmental factors on infant wheezing disorders, particularly among extremely preterm infants.
3, 14 Beck et al found that approximately one-half of the relationship between race and asthma-related hospitalization in children could be explained by socioeconomic hardships. 15, 16 This suggests that innate and acquired biological and genetic influences explain some of the racial disparity in wheezing disorders. Whether these factors relate to differences in lung structure, function, or immunity remain undefined.
The aims of the current study were to determine the relationship between maternal black race and persistent wheezing illness among former extremely low gestational age newborns (ELGAN), and to quantify, via mediation analysis, the indirect effects of socioeconomic, environmental, and innate and acquired pulmonary biological factors on the development of wheezing disorders among infants of black mothers. We hypothesized that black maternal race would be independently associated with persistent wheezing illness among former ELGAN.
Methods
This was a secondary analysis from the randomized controlled Trial of Late Surfactant (TOLSURF, ClinicalTrials.gov: NCT01022580), under Institutional Review Board approval at 25 US academic centers. 17 Infants ≤28 0/7 weeks of gestational age, who were mechanically ventilated between 7 and 14 days of life, were randomized to late surfactant and inhaled nitric oxide (iNO) vs iNO-alone. Those with major anomalies, life expectancy <7 days, or active comorbidities at time of enrollment were excluded from the trial. No difference was seen by treatment group for the primary outcome, survival without BPD at 36 weeks of postmenstrual age (by physiological testing), although infants of black mothers were less likely to have BPD after receiving iNO. 17, 18 Perinatal characteristics and sociodemographic data were collected at enrollment. To identify maternal race/ethnicity, mothers selected Hispanic/Latino vs not Hispanic/Latino and (all that apply) White/Caucasian, Black/African American, Asian, American Indian/Alaska Native, and Native Hawaiian/ Other Pacific Islander. For this study, race/ethnicity was dichotomized to black (non-Hispanic) vs nonblack. Mothers who selected multiple races were included in the nonblack group.
At discharge, parents/caregivers were surveyed for factors known to modify respiratory morbidity in former ELGAN and other children. 19 Specifically, we collected data on the presence of additional children <5 years of age in the home, furry pets in the home, anticipated daycare attendance, breast milk diet, maternal educational attainment, public insurance status, and parental history of asthma (Discharge Questionnaire, Appendix 2; available at www.jpeds.com). Potential ETS exposure was defined by factors previously shown to be associated with elevated cotinine levels in children: (1) allowing any smoking in the home, (2) having a parent or other household member who smokes, or (3) travelling regularly in a car with someone who smokes. 20, 21 Parent/caregiver questionnaires were administered at 3, 6, 9, 12, 18, and 24 months corrected (for prematurity) age to assess events related to respiratory health including exposure to inhaled medications (bronchodilators or corticosteroids), wheeze auscultated by a medical professional, and diagnosis of respiratory syncytial virus (RSV) infection. At 18 and 24 months, we asked if the child had a physician diagnosis of asthma, eczema, or hay fever. Infants were classified with a history of atopy if caregivers reported eczema or hay fever. Data collected by questionnaire were not further verified by medical record review.
We defined persistent wheezing illness as having one of the following: physician diagnosis of asthma at 18-24 months and wheezing or medication (inhaled bronchodilator or corticosteroid) exposure at any questionnaire; or medication in the first 12 months and wheeze in the second 12 months of life; or wheeze in the first 12 months and medication in the second 12 months; or medication exposure in both the first and second 12 months; or wheeze and medication exposure in the second 12 months of life reported at separate visits (18 and 24 months). These criteria were adapted from the 3-year definition used in the Vitamin D Antenatal Asthma Reduction Trial (on average, ELGAN are 21-27 months chronological age at 18-24 months corrected age).
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Statistical Analyses
Our primary question was the effect of maternal race (black vs nonblack) on persistent wheezing illness. All analyses were 2-sided (P < .05) and used Stata v 14.0 (StataCorp, College Station, Texas). Univariate analyses were analyzed by c 2 or t test. Because of the clinical importance of gestational age, sex, and birth weight, all multivariable models were adjusted for these characteristics. To evaluate the independent influence of maternal race on persistent wheezing illness, we considered other baseline characteristics that are published risk factors for respiratory illness in preterm infants (antenatal corticosteroids, birth weight percentile, product of multiple gestation, maternal age) as potential confounders (Figure 1, A) , as well as TOLSURF treatment assignment (late surfactant vs control); a priori, we planned to adjust the mediation analysis for factors that changed the effect size of maternal black race by ≥20%.
3 Generalized estimating equations accounted for nonindependence between siblings (exchangeable correlation).
We proceeded step-wise with mediation analysis. We evaluated if BPD, as well as additional sociodemographic characteristics, environmental and other exposures after hospital discharge, and family or personal history of asthma/atopy satisfied the statistical conditions required to be a mediator between maternal race and persistent wheezing illness by the following steps (Figure 1 , B) 23, 24 : (1) establish that race is significantly associated with the outcome, persistent wheezing illness, (2) establish that race is significantly associated with the potential mediator of interest, and (3) establish that the potential mediator of interest is independently associated with persistent wheezing illness, after controlling for race. If all 3 THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 198 • July 2018 conditions were met, variables were considered mediators of the relationship between maternal race and persistent wheezing illness. Finally, we used multivariable mediation analysis with dichotomous variables, while adjusting for baseline characteristics, to quantify the percent of the relationship between race and persistent wheeze explained by the pathway through each mediator (indirect effect) vs the percent explained by the pathway through race (direct effect, Figure 1 , B). As this methodology does not account for interdependence of siblings, sensitivity analyses were performed to assess the robustness of our findings. First, we selected a single sibling by random sampling, and second, we excluded all siblings.
Results
Patients were enrolled in TOLSURF from January 2010 to September 2013, with follow-up conducted through January 2016.
Of 455 infants discharged alive, 420 (92%) could be classified for persistent wheezing illness (Figure 2 ; available at www.jpeds.com). This extremely preterm cohort was predominantly male, mean gestation~25 weeks, and birth weight 700 g (Table I ), similar to the overall cohort available for 12-month follow-up. 19 When compared with those who were classified for wheezing illness, baseline characteristics of infants and their mothers who were unable to be classified (n = 29) differed somewhat from those who could be classified; they were less likely to be male (8/29, 28%; P = .002), with younger mothers (25.4 ± 5.7 years; P = .003) who were somewhat more likely to report black race (14/29, 48%; P = .13).
Overall, 189 (45%) infants had persistent wheezing illness. Infants with persistent wheeze were less likely to have received antenatal steroids and be a product of multiple gestation, but were more likely to be male, weigh more at birth, and be infants of black mothers. Late surfactant had no effect on persistent wheeze, so we did not further consider treatment assignment. After dichotomizing infants by maternal race (black vs nonblack), infants of black mothers had 2.6 (95% confidence interval [CI] 1.7, 4.0; P < .001) times the odds of developing persistent wheezing illness compared with those of nonblack mothers. The OR increased modestly (2.9, 95% CI 1.9, 4.5; P < .001) with adjustment for gestational age, sex, and birth weight.
We evaluated for the inclusion of other baseline covariates that might affect the association between maternal race and persistent wheeze. Although antenatal steroid exposure was associated with persistent wheeze while adjusting for maternal race (OR 0.47, 95% CI 0.24, 0.91; P = .03), none of the covariates substantially changed the effect of black race and were, therefore, not included in subsequent analyses (Table II; available at www.jpeds.com).
Next, we sought to determine the socioeconomic (maternal education, public insurance status), environmental (breast milk diet, ETS, young child, or furry pet in home) and biological (BPD, caregiver report of RSV infection, atopy, and parent history of asthma) factors that may mediate the relationship between maternal race and persistent wheeze (data on prevalence and unadjusted relationships with persistent wheezing illness are provided, Table III ; available at www.jpeds.com). As only 2 infants were anticipated to attend daycare, this variable was not evaluated further. Black maternal race had no significant association with potential ETS exposure, young siblings in the home, RSV, or parent history of asthma (Table IV) . Although maternal black race was associ- (4) 10 (4) 8 (4) Data reported as mean ± SD or N (%). P value by c 2 or t test. *Corresponds to step 1 from mediation analysis.
†Percentile as determined by Fenton reference curves (2013). ‡Other includes Asian, American Indian/Alaska Native, Native Hawaiian/Pacific Islander, multiple race, and unknown. ated with increased odds of infant history of eczema/hay fever, this relationship was not statistically significant (P = .08). In addition, although maternal black race was associated with decreased odds of furry pets in the home and lower educational attainment, these 2 variables were not independently associated with persistent wheeze when adjusted for maternal race and, therefore, were not considered mediators in this analysis. Black maternal race was positively associated with public insurance status and negatively associated with breast milk diet and BPD, and these variables were independently associated with persistent wheeze, while adjusting for maternal race. Thus, public insurance status, breast milk diet, and BPD were identified as mediators of the relationship between maternal black race and persistent wheezing (Table IV) . Adjusted effects of potential mediators not independently associated with black race are provided (Table V; available at www.jpeds.com). We then tested these 3 variables in a mediation analysis model (Figure 1, B) to determine the percent of the relationship between maternal race and persistent wheeze explained through direct vs indirect pathways. In this model (n = 410 infants with complete data), 69% of the relationship is explained directly by maternal black race (Table VI) . Despite the known importance of SES and environmental exposures on wheezing disorders, only 8% of the relationship between maternal black race and persistent wheeze is mediated via breast milk diet and 12% via public insurance status. BPD explained 10% of the relationship between maternal black race and persistent wheezing illness. Interestingly, the coefficient for BPD was negative, indicating that the effect of maternal black race would be underestimated if BPD were not included in the analysis. These data are consistent with an increase in the OR for black race and persistent wheezing illness after adjustment for BPD (from 2.9 to 3.5), along with the expected relationship of increased odds for BPD and persistent wheezing illness (Table IV) .
Sensitivity analyses were performed to evaluate the effect of siblings; 96 of 420 (23%) of infants had a sibling included in the mediation analysis. When a single sibling was selected at random (n = 366), changes in effects were modest ( Table VI) . The direct effect of maternal black race explained 72% of the relationship, and estimates of indirect effects of breast milk diet, public insurance status, and BPD were minimally altered. Similarly, when all siblings were excluded from the analysis (n = 317), the direct effect of maternal black race remained at 72%.
Discussion
In this cohort of former high-risk ELGAN, we quantified the increased odds of persistent wheezing illness by 24 months corrected age for infants of black mothers, compared with infants of nonblack mothers. Furthermore, we demonstrated that although breast milk diet, public insurance status, and BPD all partially mediate the relationship between maternal race and wheezing illness, a substantial proportion of the relationship is directly mediated through maternal race.
Our findings in ELGAN are consistent with previously described racial disparities in risk of wheezing disorders. In recent (2001-2013) population-based US data, annual asthma prevalence among non-Hispanic black children (0-17 years of age) ranged from 1.3 to 2.1 times that of white children. 6 Similarly, Gold et al found that black children (7-14 years of age) had increased odds (OR 1.47, 95% CI 1.25, 1.74) for persistent wheeze compared with white children. 7 Among preterm infants, several studies have demonstrated increased rates of wheezing illness for African American children compared with white children, although data on the extremely preterm are limited. [9] [10] [11] [12] [13] In infants ≥32 weeks of gestational age, African American children had increased odds of recurrent wheeze by age 3 years (OR 1.39, 95% CI 1.24, 1.56), similar to findings at 1 year corrected age for moderately preterm infants. 10, 13 In the current study, our adjusted odds ratio of 2.9 (95% CI 1.9, 4.5) suggests that the racial disparity we have documented is valid, even among high-risk ELGAN treated with iNO and classified into wheezing phenotypes as early as 24 months corrected age. Although we collected only maternal race in this study, relatedness of genetic ancestry is common among couples, so maternal race is likely a good surrogate for the child. 25 Notably, in a prior study, there was no differential effect of iNO on bronchodilator use by maternal race in ELGAN, despite the suggestion that infants of black mothers might have less BPD following iNO therapy. [26] [27] [28] Although studies have sought to determine the relationship between socioeconomic and environmental risk factors and wheezing disorders, the interrelationships of these factors and race have not been extensively studied. Beck et al demonstrated that 49% of the relationship between black race and asthma-related hospital admission in children (1-17 years of age) was attributable to financial and social hardship and SES (measured by income and educational attainment). 15 Similarly, in a follow-up study including data on environmental exposures, access to care, disease management, and biological disease-related factors, socioeconomic factors explained 53% of the racial disparity in admissions, with 80% of the racerelated variability resolving after inclusion of these additional data. 16 However, hospitalization may be more impacted by measures of lower SES for children with respiratory illness compared with other health outcomes, although data are inconsistent. [29] [30] [31] [32] Regardless, in the current study, we did not collect comprehensive data to assess SES, social stressors, and all possible environmental exposures. We did consider inclusion of maternal age and educational attainment, and a number of potential exposures that can be related to SES. 20, 21, [33] [34] [35] [36] As only public insurance status remained in our final mediation analysis, our available data and methodology may underestimate the explanatory role of social factors in the observed racial disparity. Other differences with prior studies may be due to our select study population of high-risk ELGAN, among which gestational age and birth weight could explain variability because of sociodemographic characteristics, as there are also racial disparities in preterm birth (Figure 1, A) . 37, 38 Regardless, race consistently explains a substantial proportion of disparities observed in wheezing disorders across varied patient populations. Investigators have stated that social and environmental factors must be accounted for prior to attributing those disparities to innate biological and/or genetic differences, which remain unmeasured in many studies; some differences (eg, lung function) have been mapped to specific genomic regions.
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Although we showed race directly explained about twothirds of the relationship between race and persistent wheeze, this effect likely represents a combination of both innate genetic differences and acquired biological changes (lung structure, function, and/or immunity) because of social racial disparities not specifically accounted for by our SES variables.
Breast milk diet after discharge was negatively associated with both maternal black race and persistent wheezing illness, and met criteria as a mediator in this study. Infants continuing on breast milk after discharge likely had greater exposure to breast milk during hospitalization (usually 3-4 months) as well. Prolonged breast milk diet (≥3 months) is considered protective against childhood wheezing illness and asthma, although associations are variable. 33, 34, 43 Proposed mechanisms include developmental effects on immunity and atopy. These protective effects may be greatest in atopic and young children (for which early respiratory infection is likely important). Prolonged breastfeeding is also related to socioeconomic factors, with decreased breast milk exposure associated with lower family income and maternal educational attainment, and increased rates of exposure to tobacco smoke before and after birth. 33 Thus, our findings related to breast milk diet may capture both biological effects of breast milk on development of lung immunity, and the impact of socioenvironmental exposures (Figure 1, A) .
Exposure to pre-and postnatal tobacco smoke increases risk and severity of childhood wheezing disorders, with young children most sensitive to this exposure. 20, 35, 36 In utero and postnatal smoke exposure alter lung structure and diminish function, and higher proportions of African ancestry place active smokers at greatest risk for loss of function. [44] [45] [46] Although we have documented that~25% of our population was at risk for postnatal ETS exposure, we did not assess gestational smoke exposure nor measure cotinine levels. However, other models assessing postdischarge respiratory outcomes in ELGAN did not demonstrate substantial differences in effect for reports of gestational and postdischarge smoke exposure. 47 In our analysis, potential ETS exposure was not significantly associated with maternal black race, nor was it significantly associated with persistent wheezing illness after adjustment for race. This lack of effect in our cohort may reflect our broad definition of ETS or the shared socioeconomic factors influencing preterm birth and wheezing disorders; among former ELGAN with BPD, even children who do not report household smokers can have detectable cotinine levels, biasing against an effect of reported ETS in this population. 20, 21, 36 Persistent/recurrent wheeze incidence depends on its definition. In predominantly term-born infants, incidence was 25%-30% at 3 years of age (selected for parental history of asthma/ atopy),~15% at 2 years of age, and~20% at 1 year of age. 14, 22, [48] [49] [50] However, Escobar et al recorded recurrent wheeze rates of 6.5% and 3% for late preterm and term-born infants at 3 years of age, using more stringent criteria, and Hibbs et al documented incidence of 46% at 1 year of age in moderately preterm infants. 10, 13 Our rates of persistent wheeze in high-risk ELGAN at 2 years of age are consistent with a published meta-analysis (OR 2.5-3 for children born <32 weeks of gestational age). 3 As study outcome data were by caregiver recall, there is potential for misclassification. However, caregivers can provide reliable and accurate responses related to respiratory illness in young children, with a short recall interval of 1 year demonstrating good agreement with medical records. [51] [52] [53] Various strengths and limitations of sociodemographic variables considered in this study have been discussed, but ultimately we cannot assess the specific contribution of unmeasured characteristics and exposures because of limitations of the data that were collected, which may lead to overestimation of the direct effect of maternal race. We did not collect data about specific viral infections other than RSV, which may have differential effects by race. 54 In addition, we are not able to calculate CIs around the proportions of direct and indirect effects of mediation, given the limitations of binary mediation. Further, although there is likely a biological basis (differences in lung structure, function, and immune function) for a proportion of the racial disparity we describe by accepted methodologies, the complex interactions of SES, social stressors, environment, and race preclude a conclusion based on genetic factors alone, particularly given the sociodemographic background of preterm birth. 37, 38, 41 In conclusion, we quantify, for the first time, a similar influence of maternal black race on persistent wheeze among former high-risk ELGAN as that previously shown for substantial prematurity alone, suggesting that black race exacerbates the risk of wheezing illness because of extreme prematurity. As ELGAN have decreased lung function compared with term-born controls, those born to black mothers THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 198 are at risk for further decrements in lung function with age. 55 Although we found breast milk diet and insurance status mediate the relationship between maternal race and persistent wheezing illness, a substantial proportion of the relationship is explained via the direct effect, which would be underestimated from this cohort of iNO-treated ELGAN if the diagnosis of BPD were not considered. This suggests that innate biological risk factors explain some proportion of the racial disparity observed. Future studies should better characterize and phenotype persistent wheezing illness in former preterm infants and describe the underlying innate and acquired biological and genetic causes. 
